Emmanuelle Charpentier

E74405

Emmanuelle Charpentier is a French microbiologist and geneticist best known as a co-developer of the CRISPR-Cas9 genome-editing technology, for which she received numerous prestigious scientific awards.


Statements (60)
Predicate Object
instanceOf biochemist
geneticist
human
microbiologist
molecular biologist
university teacher
academicDegree PhD in microbiology
awardReceived Breakthrough Prize in Life Sciences
Canada Gairdner International Award
Gruber Genetics Prize
Japan Prize
Kavli Prize in Nanoscience
Louis-Jeantet Prize for Medicine
L’Oréal-UNESCO For Women in Science Award
Nobel Prize in Chemistry
Nobel Prize in Chemistry 2020
Otto Warburg Medal
coDeveloperOf CRISPR-Cas9 genome-editing technology
coInventorOf CRISPR-Cas9 gene-editing method
collaboratedWith Jennifer Doudna
countryOfCitizenship France
dateOfBirth 1968-12-11
educatedAt Institut Pasteur
Pierre and Marie Curie University
employer Helmholtz Centre for Infection Research
Max Planck Institute for Infection Biology
Max Planck Unit for the Science of Pathogens
Umeå University
University of Vienna
familyName Charpentier
fieldOfWork biochemistry
genetics
microbiology
molecular biology
givenName Emmanuelle
hasResearchInterest CRISPR-Cas adaptive immunity in bacteria
RNA biology
bacterial pathogenesis
knownFor CRISPR-Cas9 gene-editing technology
CRISPR-Cas9 genome editing
research on CRISPR-Cas systems
languageSpoken English
French
memberOf European Molecular Biology Organization
German National Academy of Sciences Leopoldina
Royal Swedish Academy of Sciences
name Emmanuelle Charpentier
nationality French
notableStudentOrTrainee researchers in CRISPR-Cas9 field
notableWork discovery of CRISPR-Cas9 as a programmable genome-editing tool
placeOfBirth France
Juvisy-sur-Orge NERFINISHED
Île-de-France
positionHeld director of the Max Planck Unit for the Science of Pathogens
scientific member of the Max Planck Society
sexOrGender female
workLocation Berlin
Germany
Sweden
Umeå NERFINISHED


Please wait…